Although estrogen receptors were not identified as predicted target miR-18a-5p, a negative correlation between miR-18a-5p and ESR1 expression was demonstrated in breast tumor cells and hepatocellular cancer [73,74], indicating a potential interaction of miR-18a-5p/ESR1. The gene discussed is ESR1; the disease is hepatocellular carcinoma.